A depression screening is a short questionnaire, most often the PHQ-9, that flags possible depressive symptoms. It is not a diagnosis on its own. If your score comes back elevated, the right next step is a clinical evaluation, and if you are having thoughts of suicide, call or text 988 right away or call 911.
TL;DR:
- A positive depression screening result warrants a clinical evaluation, especially if the score is 10 or higher on the PHQ-9, which has about 85% accuracy.
- When screening indicates moderate or higher symptoms, a follow-up assessment should include reviewing symptom duration, functional impact, medical causes, substance use, and suicide risk.
- The PHQ-9's nine questions are scored from 0 to 27, with scores of 10 or more indicating a need for closer evaluation, and question 9 demands immediate attention if positive.
- Routine depression screening is recommended for adults, including pregnant, postpartum, and older individuals, but only within systems that can provide ongoing care and follow-up.
- A screening tool without a pathway to diagnosis and treatment has limited benefit; immediate help should be sought if thoughts of self-harm or suicide arise.
Table of Contents
- What a depression screening is and why it is used
- Common screening tools and when each one is used
- How to take the PHQ-9 and what your score means
- Who should be screened and how clinics implement it
- After a positive screen: assessment, treatment, and urgent steps
- How Garden State Medical Group supports evaluation and follow-up after screening
- Perspective: why routine screening matters and how patients can use results
- If you need assessment or treatment: how to contact Garden State Medical Group
- Sources
- FAQ
What a depression screening is and why it is used
A depression screening asks you to rate a set of common symptoms, things like sleep changes, low mood, and loss of interest, usually over the past two weeks. According to MedlinePlus, a screening tool estimates whether depressive symptoms may be present and how severe they might be, but it does not diagnose depression by itself. Your clinician may still order blood work to check for conditions like thyroid disease or anemia that can mimic depressive symptoms.
The value of screening comes from what happens after you take it. Research on screening programs that connect patients to actual care found measurable benefit: trials that paired screening with care management showed lower depression symptom prevalence and higher remission rates at around six months. That is the whole point of a screening tool:
- It gives you and your provider a starting number to discuss.
- It helps catch symptoms you might not label as depression, like fatigue or appetite changes.
- It only helps when it leads somewhere, meaning a conversation, an evaluation, and if needed, treatment.
Common screening tools and when each one is used
Several validated questionnaires exist, and which one you encounter often depends on your age or life stage. Most clinics start with a quick check and move to a longer one only if needed.
- PHQ-2: a two-question screen asking about mood and interest over the past two weeks, used as a fast first pass.
- PHQ-9: the standard nine-item adult screen, covering the same two-week window in more detail, typically given when the PHQ-2 is positive.
- Geriatric Depression Scale (GDS): designed for older adults, with wording adjusted for symptoms that present differently later in life.
- Edinburgh Postnatal Depression Scale (EPDS): used during pregnancy and the postpartum period, when a review found that screening tied to care follow-up reduces symptom prevalence.
Whichever tool you fill out, a positive result means the same thing: it is a reason to talk to a clinician, not a final answer.
How to take the PHQ-9 and what your score means
The PHQ-9 asks you to rate nine symptoms on a four-point scale, from "not at all" to "nearly every day," thinking only about the past two weeks. Your answers add up to a total score between 0 and 27.
The bands break down this way, based on commonly used PHQ-9 interpretation guidance:
- 0 to 4: minimal symptoms.
- 5 to 9: mild symptoms.
- 10 to 14: moderate symptoms.
- 15 to 19: moderately severe symptoms.
- 20 to 27: severe symptoms.
At a cutoff of 10 or higher, the PHQ-9 has a pooled sensitivity and specificity generally reported around 85% against structured diagnostic interviews, according to a large individual participant data meta-analysis. That means the tool correctly identifies likely depression most of the time at this threshold, though it still misses some cases and flags others that further evaluation would rule out.
One item deserves separate attention. Question 9 asks about thoughts of self-harm or suicide, and a positive answer here calls for immediate attention no matter what your total score adds up to.
Who should be screened and how clinics implement it
The USPSTF recommends routine depression screening for adults with a grade B rating, a recommendation that includes pregnant and postpartum individuals and older adults. The recommendation comes with a condition attached: screening should happen in settings where systems exist to provide diagnostic follow-up, treatment, and ongoing monitoring. Screening without that infrastructure offers far less benefit.
A few practical points follow from this:
- Screening is generally intended for people not already diagnosed with depression, since the goal is early detection.
- The USPSTF does not specify an exact screening interval, leaving frequency to clinical judgment based on your risk factors and history.
- People managing chronic conditions, such as heart disease or diabetes, are often screened more routinely, since depression can complicate those conditions.
After a positive screen: assessment, treatment, and urgent steps
A score in the moderate range or higher is a cue to schedule a visit, not a verdict. Here is generally what a follow-up evaluation covers, including guidance on distinguishing grief from depression to know when to seek care: how clinicians tell grief from depression and when to seek care.
- Symptom duration and severity, to see whether what you are experiencing fits a diagnosable pattern rather than a short-term reaction to stress.
- Functional impairment, meaning how much your symptoms affect work, relationships, or daily tasks.
- Medical contributors, since thyroid problems, certain medications, and other conditions can produce depression-like symptoms.
- Substance use and current medications, which can influence mood independently.
- Bipolar history, because antidepressants alone are not the right first step for bipolar depression.
- Suicide risk, assessed directly rather than inferred from a score.
From there, treatment commonly includes psychotherapy, medication, or a collaborative care approach combining both, with follow-up visits to track whether symptoms are improving.
Pro Tip: If you are having thoughts of suicide or self-harm, call or text 988, use the 988 chat, or call 911 if you are in immediate danger. Do not wait for a scheduled appointment.
Screening without a path to care accomplishes little. A number on a page does not treat depression; a clinician who reviews that number and acts on it does.
How Garden State Medical Group supports evaluation and follow-up after screening
A multidisciplinary setup is built for exactly this kind of follow-through. A positive screen often raises questions that need more than a conversation to answer, and that is where onsite diagnostic testing and chronic care programs come in, helping rule out thyroid issues or other contributors before settling on a mental health diagnosis.
A few ways this plays out for patients:
- Primary care visits can incorporate screening results directly into a broader health review.
- Chronic Care Management supports patients managing depression alongside other ongoing conditions.
- Telemedicine visits make it easier to schedule a follow-up quickly rather than waiting weeks for an in-person slot.
Perspective: why routine screening matters and how patients can use results
Screening earns its place in primary care because it works when paired with follow-up, not because the questionnaire itself is magic. Trials pairing screening with care management showed fewer symptoms and more remissions at six to twelve months, and the PHQ-9 doubles as a monitoring tool, letting you and your clinician track whether a treatment plan is actually moving your score down over time. Bring your number to your next visit and ask what it means for you specifically.
— Garden State Medical Group
If you need assessment or treatment: how to contact Garden State Medical Group
A positive screen deserves a real conversation, not a search engine. Primary Care visits at Garden State Medical Group give you a place to bring your screening results and get a full evaluation, including any testing needed to rule out medical causes, and the practice accepts a wide range of insurance plans.
A few things to bring along help the visit go further:
- Your completed questionnaire, if you filled one out at home.
- A current list of medications and supplements.
- Any recent lab results you have on hand.
Telemedicine visits are available if getting to an office is not practical right now. You can schedule an appointment directly through the practice.
Sources
For readers who want the primary guidance behind this article: the USPSTF recommendation on depression screening, MedlinePlus on depression screening, the PHQ-9 accuracy meta-analysis, and the NIMH overview of depression.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
- Depression screening: MedlinePlus Medical Test
- USPSTF recommendation: Depression and Suicide Risk in Adults
- Screening interventions and outcomes (systematic review/meta-analysis)
FAQ
What is a depression screening?
A depression screening is a short questionnaire, usually completed in a few minutes, that asks about mood, sleep, energy, and related symptoms over the past two weeks. According to MedlinePlus, it estimates whether symptoms may be present but does not diagnose depression on its own.
What is the PHQ-9 for depression?
The PHQ-9 is a nine-item questionnaire that is the most widely used adult depression screening tool, scoring symptoms from 0 to 27 based on the past two weeks. At a cutoff of 10 or higher, it has pooled sensitivity and specificity of about 85% compared to structured clinical interviews.
What are signs you might have depression?
Common signs include persistent sadness or emptiness, loss of interest in things you used to enjoy, changes in sleep or appetite, low energy, and trouble concentrating, according to NIMH. Some people also notice physical complaints or irritability rather than classic sadness, which is part of why a structured questionnaire like the PHQ-9 helps catch less obvious cases.
What is a normal PHQ-9 score?
A PHQ-9 score between 0 and 4 falls in the minimal symptom range, which is generally considered the baseline or "normal" band on the standard PHQ-9 scale. Scores of 5 and above move into mild, moderate, or more severe ranges and generally warrant a follow-up conversation with a clinician.